Phase II study of ruxolitinib, a selective JAK1/2 inhibitor, in patients with metastatic triple-negative breast cancerDaniel G. Stover, Nancy U. Lin, Carlos R. Gil Del Alcazar et al.|npj Breast Cancer|2018Cited by 150
Genome-scale and multi-gene phylogenetic analyses of Colletotrichum spp. host preference and associated with medicinal plantsQizhou Zhang, Chao Li, Ruvishika S. Jayawardena et al.|Mycosphere|2023Cited by 37